Focus of this position will be the role/use of cost-effectiveness and related evidence-based approaches in setting priorities for health interventions and maximising their impact.
The new issue of the SACEMA Quarterly is out and contains articles on e.g. heterogeneity and HIV prevention trials, TB control and cost-effectiveness of PrEP.